These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 29323501)

  • 1. The Pivotal Role of Copper in Neurodegeneration: A New Strategy for the Therapy of Neurodegenerative Disorders.
    Giampietro R; Spinelli F; Contino M; Colabufo NA
    Mol Pharm; 2018 Mar; 15(3):808-820. PubMed ID: 29323501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights Into the Role of Copper in Neurodegenerative Diseases and the Therapeutic Potential of Natural Compounds.
    Zhong G; Wang X; Li J; Xie Z; Wu Q; Chen J; Wang Y; Chen Z; Cao X; Li T; Liu J; Wang Q
    Curr Neuropharmacol; 2024; 22(10):1650-1671. PubMed ID: 38037913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DPM-1001 decreased copper levels and ameliorated deficits in a mouse model of Wilson's disease.
    Krishnan N; Felice C; Rivera K; Pappin DJ; Tonks NK
    Genes Dev; 2018 Jul; 32(13-14):944-952. PubMed ID: 29945887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper-dependent oxidative stress and neurodegeneration.
    Rotilio G; Carrì MT; Rossi L; Ciriolo MR
    IUBMB Life; 2000; 50(4-5):309-14. PubMed ID: 11327325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transition metals copper and iron in neurodegenerative diseases.
    Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
    Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prochelator strategies for site-selective activation of metal chelators.
    Oliveri V; Vecchio G
    J Inorg Biochem; 2016 Sep; 162():31-43. PubMed ID: 27297691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of copper in neurodegenerative disease.
    Waggoner DJ; Bartnikas TB; Gitlin JD
    Neurobiol Dis; 1999 Aug; 6(4):221-30. PubMed ID: 10448050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective divalent copper chelation for the treatment of diabetes mellitus.
    Cooper GJ
    Curr Med Chem; 2012; 19(17):2828-60. PubMed ID: 22455587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper imbalance and oxidative stress in neurodegeneration.
    Rossi L; Arciello M; Capo C; Rotilio G
    Ital J Biochem; 2006; 55(3-4):212-21. PubMed ID: 17274527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance.
    Rossi L; Lombardo MF; Ciriolo MR; Rotilio G
    Neurochem Res; 2004 Mar; 29(3):493-504. PubMed ID: 15038597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications.
    Perry G; Sayre LM; Atwood CS; Castellani RJ; Cash AD; Rottkamp CA; Smith MA
    CNS Drugs; 2002; 16(5):339-52. PubMed ID: 11994023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper dyshomoeostasis in Parkinson's disease: implications for pathogenesis and indications for novel therapeutics.
    Davies KM; Mercer JF; Chen N; Double KL
    Clin Sci (Lond); 2016 Apr; 130(8):565-74. PubMed ID: 26957644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway.
    Mandel SA; Avramovich-Tirosh Y; Reznichenko L; Zheng H; Weinreb O; Amit T; Youdim MB
    Neurosignals; 2005; 14(1-2):46-60. PubMed ID: 15956814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and functions of copper in brain.
    Scheiber IF; Mercer JF; Dringen R
    Prog Neurobiol; 2014 May; 116():33-57. PubMed ID: 24440710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases.
    Lanza V; Milardi D; Di Natale G; Pappalardo G
    Curr Med Chem; 2018 Feb; 25(4):525-539. PubMed ID: 28521682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chelating agents for neurodegenerative diseases.
    Ward RJ; Dexter DT; Crichton RR
    Curr Med Chem; 2012; 19(17):2760-72. PubMed ID: 22489724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copper handling by astrocytes: insights into neurodegenerative diseases.
    Tiffany-Castiglioni E; Hong S; Qian Y
    Int J Dev Neurosci; 2011 Dec; 29(8):811-8. PubMed ID: 21968186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress and neurodegeneration: the involvement of iron.
    Carocci A; Catalano A; Sinicropi MS; Genchi G
    Biometals; 2018 Oct; 31(5):715-735. PubMed ID: 30014355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reorganizing metals: the use of chelating compounds as potential therapies for metal-related neurodegenerative disease.
    Badrick AC; Jones CE
    Curr Top Med Chem; 2011; 11(5):543-52. PubMed ID: 21189128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.